aTyr Pharma Inc (LIFE)
1.70
-0.01
(-0.58%)
USD |
NASDAQ |
May 10, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Profit Margin (Quarterly): -6.59K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.59K% |
| December 31, 2023 | |
| September 30, 2023 | -3.21K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -72.41% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 |
| Date | Value |
|---|---|
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -240.2% |
| September 30, 2020 | -4.46K% |
| June 30, 2020 | -3.41K% |
| March 31, 2020 | 21.74% |
| December 31, 2019 | -4.15K% |
| September 30, 2019 | -3.07K% |
| June 30, 2019 | -6.22K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.59K%
Minimum
Mar 2024
21.74%
Maximum
Mar 2020
-3.14K%
Average
-3.31K%
Median
Profit Margin (Quarterly) Benchmarks
| Vaxart Inc | -262.3% |
| Allogene Therapeutics Inc | -- |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -57.64% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -55.18% |
| Return on Assets | -42.90% |
| Return on Invested Capital | -55.18% |
| Operating Margin (Quarterly) | -7.08K% |
| Return on Net Operating Assets | -246.5% |